JAMA Network Open· 2026Q1

Cefepime and Mortality

Zahra Sohani, You Zhong, Avideh Afshar, Bander A. Assiri et al.

1citations
Q1SCImago
2026year

Short summary

A meta-analysis of 110 randomized trials (22,608 patients) found a 94.4% probability that cefepime is associated with increased all-cause mortality compared to other beta-lactams (OR 1.10).

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Pharmacology

PharmacologyMedicine